[(4Z,6Z,10Z,12Z)-3-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-9-yl] acetate
Modify Date: 2025-08-25 18:26:04
![[(4Z,6Z,10Z,12Z)-3-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-9-yl] acetate Structure](https://image.chemsrc.com/caspic/489/23812-97-7.png)
[(4Z,6Z,10Z,12Z)-3-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-9-yl] acetate structure
|
Common Name | [(4Z,6Z,10Z,12Z)-3-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-9-yl] acetate | ||
|---|---|---|---|---|
| CAS Number | 23812-97-7 | Molecular Weight | 501.56900 | |
| Density | 1.22g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C27H35NO8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | [(4Z,6Z,10Z,12Z)-3-hydroxy-6,12,15,18-tetramethyl-16,19-dioxo-14-(2-oxopropanoylamino)-17-oxabicyclo[13.2.2]nonadeca-4,6,10,12-tetraen-9-yl] acetate |
|---|---|
| Synonym | More Synonyms |
| Density | 1.22g/cm3 |
|---|---|
| Molecular Formula | C27H35NO8 |
| Molecular Weight | 501.56900 |
| Exact Mass | 501.23600 |
| PSA | 136.07000 |
| LogP | 2.67940 |
| Index of Refraction | 1.552 |
| InChIKey | SXLMQJVXWZFRNQ-LDACTNBVSA-N |
| SMILES | CC(=O)OC1C=CC(C)=CC(NC(=O)C(C)=O)C2(C)C(=O)OC(CC(O)C=CC(C)=CC1)C(C)C2=O |
| Ro 23-0731/000 |
| Bundlin B |
| Lankacidin C-14-acetat,Lankacidin A |
| Sedecamicina [Spanish] |
| Lankacidin A |
| Takelan |
| Lankacidin C-8-acetat |
| Sedecamycinum [Latin] |
| Sedecamycin |
| Antibiotic T-2636 A |
| Lankacidin C 14-acetate |
| Sedecamycine [French] |